SCM Lifescience Co., Ltd.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Sep 2031
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Jun 24, 2027The maintenance fee for Pharmaceutical composition for preventing or treating hair loss comprising chemokine (C-X-C motif) ligand 1 (CXCL1) protein or CXCL1 protein and minoxidil as active ingredient (US 10,512,670) comes due Jun 24, 2027. Unpaid by Dec 27, 2027, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 5 of 5
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,439,929 | Treatment of graft-versus-host disease In force · USPTO record | In force | USPTO record | |
| US 10,512,670 | Pharmaceutical composition for preventing or treating hair loss comprising chemokine (C-X-C motif) ligand 1 (CXCL1) protein or CXCL1 protein and minoxidil as active ingredient In force · USPTO record | In force | USPTO record | |
| US 11,096,967 | Pharmaceutical composition for preventing or treating regulatory T cell-mediated diseases In force · USPTO record | In force | USPTO record | |
| US 11,248,210 | Method for isolation of stem cells from bone marrow using subfractionation culturing method and proliferation thereof In force · USPTO record | In force | USPTO record | |
| US 11,413,313 | Pharmaceutical composition for preventing or treating atopic dermatitis comprising clonal stem cells In force · USPTO record | In force | USPTO record |
Also on record, not counted in the 5: 2 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
1 pending · 4 abandoned · 6 no status recorded
Showing 1 to 10 of 11, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.
| Application | Title | Filed | Status |
|---|---|---|---|
| 18/697,153 | Human Bone Marrow-Derived Mesenchymal Stem Cell Sheets and Methods for Their Production | Sep 30, 2022 | Pending |
| 18/566,349 | Combined Administration Composition for Preventing or Treating Atopic Dermatitis, Comprising Function-Enhanced Stem Cells and Regulatory T Cells | May 30, 2022 | Abandoned |
| 18/561,930 | Composition Containing Function-Reinforced Stem Cell for Prevention or Treatment of Atopic Dermatitis | May 18, 2022 | Abandoned |
| 18/259,130 | Dec 21, 2021 | No status recorded | |
| 17/791,096 | Composition for Reinforcing Function of Stem Cell | Nov 24, 2020 | Abandoned |
| 17/607,758 | Apr 27, 2020 | No status recorded | |
| 17/440,488 | Mar 18, 2020 | No status recorded | |
| 17/414,495 | Pharmaceutical Composition Comprising Clonal Stem Cells for Treating Graft-Versus-Host Disease | Dec 4, 2019 | Abandoned |
| 17/413,641 | Dec 4, 2019 | No status recorded | |
| 16/331,426 | Sep 7, 2017 | No status recorded |
10 of 11 applications shown.
Pro members see all 11 published applications.